Understanding how a brain region affects reward and cocaine addiction
Zona Incerta Contributions to Reward and Cocaine Addiction
This study is looking at how a part of the brain called the zona incerta affects motivation and addiction, especially to cocaine, to help us understand more about impulsive behaviors and find better ways to treat addiction.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical College of Wisconsin NIH-funded |
| Lab location | 1 site (Milwaukee, United States) |
| Project ID | NIH-10651652 on NIH RePORTER |
What this research studies
This research investigates the role of the zona incerta (ZI), a brain structure, in influencing motivation and addiction behaviors, particularly in relation to cocaine. By using advanced techniques such as optogenetics and electrophysiology, the study aims to explore how the ZI connects to the ventral tegmental area (VTA), which is crucial for reward processing. The research will involve both animal models and human data to uncover the mechanisms behind impulsive behaviors and addiction. Patients may benefit from insights gained about the brain's reward pathways and their implications for treating addiction.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals struggling with cocaine addiction or those exhibiting impulsive behaviors.
Not a fit: Patients who do not have issues related to addiction or impulsive behavior may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment strategies for cocaine addiction and related motivational disorders.
How similar studies have performed: Previous research has indicated that understanding brain circuitry related to addiction can lead to significant advancements in treatment, suggesting this approach has potential for success.
Where this research is happening
Milwaukee, United States
- Medical College of Wisconsin — Milwaukee, United States (Active)
Researchers
- Principal investigator: Liu, Qing-Song — Medical College of Wisconsin
- Study coordinator: Liu, Qing-Song
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.